新东方(09901) - 2026 Q1 - 季度业绩

2025-10-28 10:24
NEW ORIENTAL EDUCATION & TECHNOLOGY GROUP INC. 新 東 方 教 育 科 技( 集 團 )有 限 公 司 * (於開曼群島存續的有限公司) (股份代號:9901) 截 至 2025 年 8 月 3 1 日止第一季度的 未經審核財務業績 香港交易及結算所有限公司及香港聯合交易所有限公司(「香港聯交所」)對本公告的內容概不負責,對其準確性 或完整性亦不發表任何聲明,並明確表示概不會就本公告全部或任何部分內容而產生或因倚賴該等內容而引致 的任何損失承擔任何責任。 我們謹此公佈截至2025年8月31日止第一個財政季度的未經審核業績(「財務業績」)。財 務業績在香港聯交所網站( www.hkexnews.hk )及我們的網站( http://investor.neworiental.org/ ) 可供查閱。 承董事會命 New Oriental Education & Technology Group Inc. 新東方教育科技(集團)有限公司* 主席 俞敏洪先生 中國北京,2025年10月28日 於本公告日期,本公司董事會包括董事俞敏洪先生、周成剛先生及謝東螢先生;以及獨立董 ...
青岛港(06198) - 2025 Q3 - 季度业绩

2025-10-28 10:18
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性或完整性 亦不發表任何聲明,並明確表示,概不對因本公告全部或任何部分內容而產生或因依賴該等內容而引致 的任何損失承擔任何責任。 Qingdao Port International Co., Ltd. 青島港國際股份有限公司 (於中華人民共和國成立的股份有限公司) (股份代號:06198) 2025年第三季度報告 本公告乃青島港國際股份有限公司(「本公司」或「公司」)根據香港聯合交易所有限 公司證券上市規則第 13.09 條及香港法例第 571 章證券及期貨條例第 XIVA 部項下內幕 消息條文作出。 本公司董事會(「董事會」)欣然宣佈本公司及其附屬公司截至2025年9月30日止九個月 期間之未經審計的季度業績。 一、 重要內容提示 - 1 - 1.1 本公司董事會、董事、高級管理人員保證本季度報告內容的真實、準確、完整,不存 在虛假記載、誤導性陳述或重大遺漏,並承擔個別和連帶的法律責任。 1.2 本公司負責人、主管會計工作負責人及會計機構負責人(會計主管人員)保證本季 度報告中財務信息的真實、準確、完整。 1.3 第三季度財務 ...
白云山(00874) - 2025 Q3 - 季度业绩

2025-10-28 10:08
Financial Performance - The company's operating revenue for the third quarter reached CNY 19,771,447,682, representing a year-on-year increase of 9.74%[7] - Total profit for the quarter was CNY 1,093,686,290, marking a significant increase of 40.82% compared to the same period last year[7] - Net profit attributable to shareholders was CNY 793,911,091, reflecting a growth of 30.28% year-on-year[7] - Basic earnings per share for the quarter stood at CNY 0.488, an increase of 30.28% compared to the previous year[7] - Total operating revenue for the first three quarters of 2025 reached ¥61.61 billion, an increase of 4.2% compared to ¥59.06 billion in the same period of 2024[31] - Total operating costs for the first three quarters of 2025 were ¥57.78 billion, up from ¥55.41 billion in 2024, reflecting a growth of 4.3%[31] - Net profit for the first three quarters of 2025 was ¥3.40 billion, compared to ¥3.29 billion in 2024, representing an increase of 3.3%[32] - The company reported a total profit of ¥4.18 billion for the first three quarters of 2025, compared to ¥4.01 billion in 2024, indicating a growth of 4.4%[32] - Total comprehensive income for the first three quarters of 2025 reached CNY 3,391,689,202.13, compared to CNY 3,294,891,696.02 in the same period of 2024, reflecting an increase of approximately 2.95%[33] - Basic and diluted earnings per share for the first three quarters of 2025 were CNY 2.036, up from CNY 1.943 in 2024, representing an increase of about 4.79%[33] Assets and Liabilities - The company's total assets at the end of the reporting period were CNY 83,169,260,288, up 1.82% from the end of the previous year[9] - Shareholders' equity attributable to the company increased by 5.58% to CNY 37,906,307,061 compared to the previous year-end[9] - The company's total liabilities as of September 30, 2025, amounted to ¥43.19 billion, a slight decrease from ¥43.91 billion at the end of 2024[29] - Current liabilities totaled ¥37.74 billion as of September 30, 2025, down from ¥38.92 billion at the end of 2024, indicating a reduction of 3.0%[29] - Non-current liabilities increased to ¥5.45 billion as of September 30, 2025, compared to ¥4.99 billion at the end of 2024, marking a rise of 9.2%[29] - The company's retained earnings reached ¥23.82 billion as of September 30, 2025, up from ¥21.82 billion at the end of 2024, reflecting an increase of 9.2%[29] Cash Flow - The net cash flow from operating activities showed a significant decline, amounting to (CNY 1,971,973,586), a decrease of 162.45% year-on-year[7] - Cash inflow from operating activities totaled CNY 54,539,125,266.81 in 2025, slightly down from CNY 55,018,985,333.25 in 2024, indicating a decrease of approximately 0.87%[35] - Cash outflow from operating activities increased to CNY 56,511,098,852.89 in 2025, compared to CNY 55,770,347,563.45 in 2024, marking an increase of about 1.33%[36] - Net cash flow from operating activities for the first three quarters of 2025 was negative CNY 1,971,973,586.08, worsening from negative CNY 751,362,230.20 in 2024[36] - Cash inflow from investment activities significantly rose to CNY 7,031,185,327.43 in 2025, compared to CNY 698,340,504.82 in 2024, showing a substantial increase of approximately 909.06%[36] - Net cash flow from investment activities was negative CNY 3,421,114,034.78 in 2025, an improvement from negative CNY 4,239,805,542.16 in 2024[36] - Cash inflow from financing activities increased to CNY 10,783,209,577.82 in 2025, compared to CNY 8,534,366,363.04 in 2024, reflecting an increase of about 26.19%[37] - Net cash flow from financing activities for the first three quarters of 2025 was positive CNY 1,006,364,008.77, compared to CNY 587,309,332.49 in 2024, indicating an increase of approximately 71.14%[37] - The ending cash and cash equivalents balance for the first three quarters of 2025 was CNY 11,920,281,249.10, down from CNY 15,424,695,678.20 in 2024, representing a decrease of about 22.73%[37] Current Assets and Inventory - As of September 30, 2025, total current assets amounted to CNY 60,436,093,365.81, an increase from CNY 57,762,228,309.37 as of December 31, 2024, reflecting a growth of approximately 2.92%[24] - The company's cash and cash equivalents decreased to CNY 13,708,456,362.90 from CNY 18,273,150,112.58, representing a decline of about 25.5%[24] - Accounts receivable increased significantly to CNY 19,134,817,688.17, up from CNY 15,725,982,661.17, indicating a growth of approximately 21.5%[24] - Total non-current assets decreased to CNY 22,733,166,922.22 from CNY 23,921,383,211.27, a decline of about 4.97%[25] - The total assets of the company reached CNY 83,169,260,288.03, compared to CNY 81,683,611,520.64 at the end of 2024, marking an increase of approximately 1.82%[25] - The company reported a significant increase in inventory, which decreased to CNY 11,080,685,715.39 from CNY 12,811,902,453.79, reflecting a decline of about 13.5%[24] Research and Development - Research and development expenses for the first three quarters of 2025 were ¥443.72 million, a decrease of 23.3% from ¥578.51 million in the same period of 2024[31] Market and Strategic Plans - The company plans to enhance market expansion efforts and invest in new product development to drive future growth[17] Other Information - The company has not disclosed any new product developments or technological advancements during the reporting period[22] - There were no changes in the participation of major shareholders in financing and securities lending activities[21] - The company has not reported any mergers or acquisitions in the recent period[22] - There are no significant reminders or additional important information regarding the company's operational situation during the reporting period[22]
亚洲水泥(中国)(00743) - 2025 Q3 - 季度业绩
2025-10-28 09:36
Financial Performance - For the nine months ended September 30, 2025, the company reported an unaudited consolidated profit attributable to owners of approximately RMB 146,272,000[2]. - Total revenue for the nine months was RMB 4,118,612,000, compared to RMB 3,731,711,000 for the same period in 2024, representing an increase of approximately 10.4%[4]. - Gross profit for the period was RMB 224,885,000, down from RMB 563,931,000 in the previous year, indicating a decline of approximately 60.1%[4]. - The company recorded a loss before tax of RMB 273,254,000, compared to a profit of RMB 213,523,000 in the same period last year[4]. - The company reported a basic loss per share of RMB (0.293) for the current period, compared to a profit of RMB 0.093 in the previous year[4]. - The company did not recommend the payment of dividends for the nine months ended September 30, 2025, consistent with the previous year[8]. Cash Flow and Assets - The net cash used in investing activities was RMB 3,556,137,000, reflecting significant investment outflows[6]. - As of September 30, 2025, total assets amounted to RMB 17,414,366,000, compared to RMB 17,400,006,000 at the end of 2024[5]. - Non-current assets totaled RMB 8,891,959,000, slightly down from RMB 12,577,530,000 at the end of 2024[5]. - The company experienced a net decrease in cash and cash equivalents of RMB (75,769,000) during the period, with cash and cash equivalents at RMB 1,656,850,000 as of September 30, 2025[6]. Market Conditions - In Q3 2025, China's GDP reached RMB 101.5 trillion, growing by 5.2% year-on-year[9]. - From January to September 2025, national cement production totaled 1.259 billion tons, a decrease of 5.2% year-on-year[10]. - The average selling price of cement for the group from January to September 2025 remained roughly the same as the previous year despite initial high prices[10]. - The cement market in the Yangtze River region faced significant challenges in Q3 2025, with prices remaining low due to weak demand[9]. - In the Sichuan region, the implementation of staggered production policies helped alleviate supply-demand imbalances, leading to a second round of price increases[10]. Future Outlook and Strategy - The group expects a moderate recovery in national cement demand in Q4 2025, driven by some key infrastructure projects accelerating construction[11]. - The group plans to adhere to a strategy of high efficiency, quality, service, and environmental protection to maintain market share[12]. - The Ministry of Industry and Information Technology issued a plan to address overcapacity in the building materials industry, aiming to rationalize supply-side development[11]. - The group anticipates that industry prices will depend heavily on the execution of staggered production policies and corporate discipline[11]. - The group aims to improve performance in Q4 2025 based on market assessments and strategic initiatives[12].
绿领控股(00061) - 2025 - 年度业绩
2025-10-28 09:35
Investment and Debt Repayment - The company is actively engaging with potential investors to discuss investment terms and full repayment of 2017 noteholder debts, with a meeting scheduled for early November 2025[5] - Ongoing negotiations with other creditors to defer actions until the group's debt restructuring plan is implemented, with no refusals or repayment demands from creditors as of the announcement date[7] - Discussions with joint venture companies regarding repayment terms are ongoing, with no repayment demands from joint ventures at the time of the announcement[7]
万洲国际(00288) - 2025 Q3 - 季度业绩

2025-10-28 09:30
Financial Performance - Revenue increased by 8.5% to $20,477 million compared to $18,866 million in the previous year[4] - Operating profit rose by 7.3% to $1,926 million from $1,795 million year-on-year[4] - Profit attributable to the company's owners increased by 8.0% to $1,168 million, with basic earnings per share rising to 9.10 cents from 8.43 cents[4] - Total assets increased to $22,014 million from $19,841 million year-on-year[3] Sales and Market Trends - Total meat product sales volume decreased by 2.2%, while pork sales volume increased by 8.4%[3] - In North America, pork sales volume increased by 5.1%, contributing to a 12.0% rise in pork revenue[11] - Average pig prices in China fell by 10.7% to RMB 15.1 per kg, while in the US, prices rose by 13.2% to $1.60 per kg[6] Strategic Focus and Goals - The company plans to focus on core meat products and improve operational efficiency in pork processing[13] - The company aims to enhance profitability through key performance indicators in pig farming and increasing the added value of pork products[13] Corporate Governance and Leadership - The executive directors include Mr. Wan Long, Mr. Guo Lijun, Mr. Wan Hongwei, and Mr. Ma Xiangjie, highlighting the leadership team[14] - The non-executive director is Mr. Jiao Shuge, which may indicate governance structure[14] - Independent non-executive directors include Mr. Huang Ming, Mr. Liu Zhantian, and Ms. Zhou Hui, ensuring independent oversight[14] Financial Review and Future Outlook - The financial data for the nine months ending September 30, 2025, has not been audited but has been reviewed by the Board's Audit Committee[14] - The announcement date is October 28, 2025, indicating the timeliness of the financial review[14] - The financial performance summary is pending further details, suggesting a focus on future disclosures[14] - Future outlook and performance guidance are not mentioned, suggesting uncertainty in projections[14] Operational Insights - No specific user data or performance metrics were provided in the document, indicating a lack of detailed operational insights[14] - There are no updates on new product or technology developments, indicating a potential area for future announcements[14] - Market expansion and acquisition strategies are not discussed, which may reflect current strategic priorities[14] Corporate Actions - The company completed a secondary offering of Smithfield Foods, raising approximately $505 million[12]
山东墨龙(00568) - 2025 Q3 - 季度业绩

2025-10-28 09:25
Financial Performance - The company's operating revenue for the third quarter was CNY 397,246,057.55, a decrease of 0.81% compared to the same period last year, while the year-to-date revenue reached CNY 1,194,766,367.29, an increase of 18.87%[6] - The net profit attributable to shareholders for the third quarter was a loss of CNY 6,732,685.90, representing a 93.57% decline year-on-year, while the year-to-date net profit was CNY 5,430,990.16, down 91.70%[6] - The basic and diluted earnings per share for the third quarter were both CNY (0.0084), a decrease of 93.60% compared to the same period last year, with year-to-date earnings per share at CNY 0.0068, down 91.71%[6] - Total operating revenue for the current period reached ¥1,194,766,367.29, an increase of 18.83% compared to ¥1,005,111,902.89 in the previous period[32] - Net profit for the current period was ¥5,206,349.06, a significant decrease of 91.93% from ¥64,612,588.78 in the previous period[33] - Basic and diluted earnings per share were both ¥0.0068, down from ¥0.0820 in the previous period[35] Cash Flow and Liquidity - The net cash flow from operating activities for the year-to-date period was CNY 223,948,223.90, an increase of 328.79% compared to the previous year[6] - Cash inflow from operating activities totaled ¥1,702,283,987.08, compared to ¥1,107,475,340.06 in the previous period, representing a growth of 53.47%[36] - Cash inflow from financing activities amounted to $2,017,944,515.52, down from $2,772,744,400.69[38] - The ending cash and cash equivalents balance was $155,825,160.09, significantly higher than $13,963,888.72 at the end of the previous period[38] - The company reported a cash outflow of $2,064,090,369.07 for debt repayment, compared to $2,900,695,394.98 previously[38] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,525,655,767.97, reflecting a 4.36% increase from the end of the previous year[6] - Total current assets amounted to RMB 1,883,208,185.22, a decrease from RMB 1,935,407,894.38 at the beginning of the period[27] - Non-current assets totaled RMB 642,447,582.75, increasing from RMB 484,774,982.76 at the beginning of the period[29] - Total liabilities increased to ¥2,028,123,898.08 from ¥1,928,288,812.05, marking a rise of 5.19%[30] - The company reported short-term borrowings of RMB 1,375,664,448.79, slightly down from RMB 1,425,765,913.39 at the beginning of the period[29] Investments and Receivables - Accounts receivable increased by 232.99% to CNY 93,491,883.02, primarily due to the receipt of commercial acceptance bills[11] - Long-term equity investments surged by 2,400.30% to approximately 41.67 million, primarily from external investments[12] - The company’s accounts receivable rose to RMB 266,675,896.59 from RMB 220,326,415.43 at the beginning of the period[27] Expenses and Cost Management - Management expenses decreased by 69.42% to approximately 28.99 million, due to cost control measures and reduced expenses after equity transfers[15] - Research and development expenses for the current period were ¥26,412,555.10, up from ¥21,513,788.05, indicating a growth of 22.67%[32] Shareholder Information - The number of common shareholders at the end of the reporting period was 62,291, with significant holdings by Hong Kong Central Clearing and Shouguang Molong Holdings[20] - The equity attributable to shareholders at the end of the reporting period was CNY 497,892,052.87, a slight increase of 1.14% from the previous year[6] Other Notable Events - The company completed a debt transfer and restructuring agreement, transferring a debt of RMB 169.1198 million to a wholesale company, receiving RMB 84 million in cash and properties valued at RMB 85.1198 million[23] - The company did not conduct an audit for the third quarter financial report[39] - The financial report was issued by the board of directors led by Chairman Han Gaogui[40]
秦港股份(03369) - 2025 Q3 - 季度业绩

2025-10-28 09:18
(於中華人民共和國註冊成立的股份有限公司) (股份代號:03369) 二零二五年第三季度報告 秦皇島港股份有限公司(「本公司」或「公司」或「母公司」或「秦港股份」)董事會(「董事會」)欣然呈遞本公 司及其附屬公司(統稱「本集團」)截至二零二五年九月三十日止第三季度未經審計業績。本公告乃根 據香港聯合交易所有限公司證券上市規則第13.09(2)條及第13.10B條以及香港法例第571章證券及期 貨條例第XIVA部項下之內幕消息條文作出。 重要內容提示 公司董事會及董事、高級管理人員保證季度報告內容的真實、準確、完整,不存在虛假記載、誤導 性陳述或重大遺漏,並承擔個別和連帶的法律責任。 公司負責人、主管會計工作負責人及會計機構負責人(會計主管人員)保證季度報告中財務報表信息 的真實、準確、完整。 第三季度財務報表是否經審計 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性或完 整性亦不發表任何聲明,並明確表示概不對因本公告全部或任何部份內容而產生或因倚賴該等內容 而引致的任何損失承擔任何責任。 □是 ✓否 * 僅供識別 1 一、主要財務數據 (一)主要會計數據和財務指標 單位:元 ...
中石化油服(01033) - 2025 Q3 - 季度业绩

2025-10-28 09:09
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負 責,對其準確性或完整性亦不發表任何聲明,並明確表示概不就因本公告全部或 任何內容而產生或因依賴有關內容而引致的任何損失承擔任何責任。 (股份代號:1033) 二零二五年第三季度報告 本公告由中石化石油工程技術服務股份有限公司(「本公司」)根據香港聯合交 易所有限公司(「香港聯交所」)證券上市規則第 13.09(2)(a)條規定及上海證券 交易所相關規則而作出。 本公司董事會(「董事會」)謹此呈上本公司及其附屬公司截至 2025 年 9 月 30 日止之第三季度業績。 重要內容提示 1.本公司董事會、監事會及董事、監事、高級管理人員保證季度報告內容的真實、 準確、完整,不存在虛假記載、誤導性陳述或重大遺漏,並承擔個別和連帶的法 律責任。 2.本公司董事長吳柏志先生、總經理張建闊先生、總會計師程中義先生及財務資 產部經理張雪平女士保證季度報告中財務報表信息的真實、準確、完整。 3.第三季度財務報表是否經審計 □是 √否 中石化石油工程技術服務股份有限公司 (在中華人民共和國註冊成立之股份有限公司) | | | 本報告期 | | 年初至報告期 | ...
复星医药(02196) - 2025 Q3 - 季度业绩

2025-10-28 09:03
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性或完整性亦不 發表任何聲明,並明確表示,概不對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損 失承擔任何責任。 上 海 復 星 醫 藥( 集 團 )股 份 有 限 公 司 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.* ( 於中華人民共和國註冊成立的股份有限公司) (股份代號:02196) 2025年第三季度報告 下文為上海復星醫藥( 集團 )股份有限公司(「本公司」,連同其附屬公司,統稱「本集團」)截 至2025年9月30日止三個月(「報告期」、「本報告期」)之2025年第三季度報告(「2025年第三季 度報告」)。該財務報告乃按照中國企業會計準則編製,且未經審計。 承董事會命 上海復星醫藥(集團)股份有限公司 董事長 陳玉卿 中國,上海 2025年10月28日 於本公告日期,本公司之執行董事為陳玉卿先生、關曉暉女士、文德鏞先生及王可心先生;本公司之非執行 董事為陳啟宇先生及潘東輝先生;本公司之獨立非執行董事為余梓山先生、王全弟先生、Chen Penghui先生 ...